Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05028751
Status:
TERMINATED
Last Update Posted:
2024-04-22
First Post:
2021-08-25
Brief Title:
A Study to Evaluate Lanraplenib LANRA in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia AML
Sponsor:
Organization:
Kronos Bio